BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
BioHarvest Sciences (NASDAQ: BHST) has scheduled its Q4 and full year 2024 earnings release for March 31, 2025, after market close. The company will host an investor conference call and webcast at 4:30 p.m. Eastern time on the same day.
The earnings call will include a discussion of financial results, corporate updates, and a Q&A session. Participants can join using U.S./Canada dial-in (1-844-825-9789) or International dial-in (1-412-317-5180) with Conference ID 10197712. A replay will be available through April 14, 2025, using pin number 10197712.
BioHarvest Sciences (NASDAQ: BHST) ha programmato la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 31 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica per gli investitori e una trasmissione in webcast alle 16:30 ora orientale dello stesso giorno.
La chiamata sugli utili includerà una discussione sui risultati finanziari, aggiornamenti aziendali e una sessione di domande e risposte. I partecipanti possono unirsi utilizzando il numero per gli Stati Uniti/Canada (1-844-825-9789) o il numero internazionale (1-412-317-5180) con l'ID Conferenza 10197712. Una registrazione sarà disponibile fino al 14 aprile 2025, utilizzando il numero PIN 10197712.
BioHarvest Sciences (NASDAQ: BHST) ha programado la publicación de sus resultados del cuarto trimestre y del año completo 2024 para el 31 de marzo de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica para inversores y una transmisión web a las 4:30 p.m. hora del Este el mismo día.
La llamada sobre resultados incluirá una discusión de los resultados financieros, actualizaciones corporativas y una sesión de preguntas y respuestas. Los participantes pueden unirse utilizando el número de EE. UU./Canadá (1-844-825-9789) o el número internacional (1-412-317-5180) con el ID de Conferencia 10197712. Se podrá acceder a una repetición hasta el 14 de abril de 2025, utilizando el número PIN 10197712.
BioHarvest Sciences (NASDAQ: BHST)는 2024년 4분기 및 연간 실적 발표를 2025년 3월 31일 시장 마감 후로 예정하고 있습니다. 회사는 같은 날 동부 표준시 오후 4:30에 투자자 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다.
실적 발표 콜에서는 재무 결과, 회사 업데이트 및 Q&A 세션이 포함될 것입니다. 참가자는 미국/캐나다 전화번호 (1-844-825-9789) 또는 국제 전화번호 (1-412-317-5180)를 사용하여 회의 ID 10197712로 참여할 수 있습니다. 재생은 2025년 4월 14일까지 PIN 번호 10197712를 사용하여 이용할 수 있습니다.
BioHarvest Sciences (NASDAQ: BHST) a prévu la publication de ses résultats du quatrième trimestre et de l'année complète 2024 pour le 31 mars 2025, après la fermeture du marché. L'entreprise organisera une conférence téléphonique pour les investisseurs et un webinaire à 16h30 heure de l'Est le même jour.
La conférence sur les résultats comprendra une discussion sur les résultats financiers, des mises à jour de l'entreprise et une session de questions-réponses. Les participants peuvent se joindre en utilisant le numéro pour les États-Unis/Canada (1-844-825-9789) ou le numéro international (1-412-317-5180) avec l'ID de conférence 10197712. Un enregistrement sera disponible jusqu'au 14 avril 2025, en utilisant le numéro PIN 10197712.
BioHarvest Sciences (NASDAQ: BHST) hat die Veröffentlichung der Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf den 31. März 2025 nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Investorenkonferenzschaltung und einen Webcast veranstalten.
Der Ergebnisanruf umfasst eine Diskussion über die finanziellen Ergebnisse, Unternehmensupdates und eine Fragerunde. Teilnehmer können sich über die US/Canada-Dial-In-Nummer (1-844-825-9789) oder die internationale Dial-In-Nummer (1-412-317-5180) mit der Konferenz-ID 10197712 einwählen. Eine Wiederholung wird bis zum 14. April 2025 mit der PIN-Nummer 10197712 verfügbar sein.
- None.
- None.
Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 after market close on Monday, March 31, 2025.
Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Monday, March 31, 2025, to discuss the Company's fourth quarter and full year 2024 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:
Fourth Quarter FY2024 Results Conference Call
Date: Monday, March 31, 2025
Time: 4:30 p.m. Eastern time
U.S./Canada Dial-in: 1-844-825-9789
International Dial-in: 1-412-317-5180
Conference ID: 10197712
Webcast: BHST Q4 FY2024 Earnings Conference Call
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A telephone playback of the call will be available through Monday, April 14, 2025. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 10197712. A webcast replay will also be available at the webcast link above.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHST@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244780
FAQ
When will BioHarvest Sciences (BHST) release its Q4 2024 earnings?
How can investors join the BHST Q4 2024 earnings call?
What is the replay information for BHST's Q4 2024 earnings call?
What time is BioHarvest Sciences (BHST) Q4 2024 earnings call?
